Concerns about methodology on "Curbing COVID-19 progression and mortality with traditional Chinese medicine among hospitalized patients with COVID-19″

Pharmacol Res. 2022 Nov:185:106447. doi: 10.1016/j.phrs.2022.106447. Epub 2022 Sep 13.
No abstract available

Keywords: COVID-19; Residual confounders; Traditional Chinese Medication.

Publication types

  • Letter

MeSH terms

  • COVID-19*
  • China / epidemiology
  • Drugs, Chinese Herbal*
  • Humans
  • Medicine, Chinese Traditional / methods
  • SARS-CoV-2

Substances

  • Drugs, Chinese Herbal